Savara SVRA
NASDAQ SVRA
$5.38 +0.01 (+0.09%)
As of: Sep 4, 2026 · 3:23 PM EDT

Savara (SVRA) Sales of Property, Plant and Equipment (2010 - 2011)

Analysis

Savara (SVRA) Sales of Property, Plant and Equipment (2010 - 2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Vertex Pharmaceuticals 138.37 Bn 130.52 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.18 Bn 3.93 Bn -
3 Argenx Se 63.33 Bn 58.15 Bn 1.37 Bn -
4 Moderna 57.92 Bn 52.78 Bn 52.00 Mn -
5 Revolution Medicines 43.98 Bn 43.98 Bn - -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn 5.85 Mn
7 Alnylam Pharmaceuticals 35.48 Bn 32.17 Bn 992.69 Mn -
8 Royalty Pharma 28.42 Bn 27.58 Bn - -
9 Insmed 27.38 Bn 26.22 Bn 358.27 Mn -
10 Savara 1.36 Bn 1.36 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2011 12,635.00
Dec 31, 2010 2,679.00